Rockefeller Capital Management L.P. Eagle Pharmaceuticals, Inc. Transaction History

Rockefeller Capital Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	BUY	$24.98 - $39.77 $7,119 - $11,334	285 Added 633.33%	330 $9,000
Q3 2022 Nov 02, 2022	SELL	$26.42 - $47.12 $2,826 - $5,041	-107 Reduced 70.39%	45 $1,000
Q2 2022 Aug 12, 2022	BUY	$41.26 - $51.35 $6,271 - $7,805	152 New	152 $6,000
Q1 2021 May 11, 2021	SELL	$40.32 - $50.97 $766 - $968	-19 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$41.72 - $51.34 $792 - $975	19 New	19 $0
Q3 2020 Nov 13, 2020	SELL	$37.02 - $51.28 $592 - $820	-16 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$43.24 - $55.02 $691 - $880	16 New	16 $1,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.